These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37904980)

  • 1. Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade.
    Shu DH; Ho WJ; Kagohara LT; Girgis A; Shin SM; Danilova L; Lee JW; Sidiropoulos DN; Mitchell S; Munjal K; Howe K; Bendinelli KJ; Qi H; Mo G; Montagne J; Leatherman JM; Lopez-Vidal TY; Zhu Q; Huff AL; Yuan X; Hernandez A; Coyne EM; Zaidi N; Zabransky DJ; Engle LL; Ogurtsova A; Baretti M; Laheru D; Durham JN; Wang H; Anders R; Jaffee EM; Fertig EJ; Yarchoan M
    bioRxiv; 2023 Oct; ():. PubMed ID: 37904980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer.
    J Gunderson A; Rajamanickam V; Bui C; Bernard B; Pucilowska J; Ballesteros-Merino C; Schmidt M; McCarty K; Philips M; Piening B; Dubay C; Medler T; Newell P; Hansen P; Tran E; Tang E; Bifulco C; Crittenden M; Gough M; Young KH
    Oncoimmunology; 2021 Mar; 10(1):1900635. PubMed ID: 33796412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13
    Hu C; You W; Kong D; Huang Y; Lu J; Zhao M; Jin Y; Peng R; Hua D; Kuang DM; Chen Y
    Gastroenterology; 2024 Jun; 166(6):1069-1084. PubMed ID: 38445519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma.
    Deguchi S; Tanaka H; Suzuki S; Natsuki S; Mori T; Miki Y; Yoshii M; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M
    BMC Cancer; 2022 Jun; 22(1):699. PubMed ID: 35751038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma.
    Liu Z; Meng X; Tang X; Zou W; He Y
    Cancer Immunol Immunother; 2023 Jun; 72(6):1505-1521. PubMed ID: 36481914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade.
    Bai X; Zhou Y; Yokota Y; Matsumoto Y; Zhai B; Maarouf N; Hayashi H; Carlson R; Zhang S; Sousa A; Sun B; Ghanbari H; Dong X; Wands JR
    J Exp Clin Cancer Res; 2022 Apr; 41(1):132. PubMed ID: 35392977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Existence of intratumoral tertiary lymphoid structures is associated with immune cells infiltration and predicts better prognosis in early-stage hepatocellular carcinoma.
    Li H; Wang J; Liu H; Lan T; Xu L; Wang G; Yuan K; Wu H
    Aging (Albany NY); 2020 Feb; 12(4):3451-3472. PubMed ID: 32087064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Tumor Immune Landscape and Architecture of Tertiary Lymphoid Structures in Urothelial Cancer.
    van Dijk N; Gil-Jimenez A; Silina K; van Montfoort ML; Einerhand S; Jonkman L; Voskuilen CS; Peters D; Sanders J; Lubeck Y; Broeks A; Hooijberg E; Vis DJ; van den Broek M; Wessels LFA; van Rhijn BWG; van der Heijden MS
    Front Immunol; 2021; 12():793964. PubMed ID: 34987518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte Function in Tertiary Lymphoid Structures Predicts Hepatocellular Carcinoma Outcome.
    Li J; Xu H; Han J; Sun P; Zhang X; Wang H; Bian T; Xu Q; Ji J; Huang J
    Lab Invest; 2024 Nov; 104(11):102144. PubMed ID: 39343010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of tertiary lymphoid structures against hepatocellular carcinoma: New findings from a genetic perspective.
    Jia W; Yao Q; Wang Y; Mao Z; Zhang T; Li J; Nie Y; Lei X; Shi W; Song W
    Front Immunol; 2022; 13():1007426. PubMed ID: 36189217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial multi-omics reveal intratumoral humoral immunity niches associated with tertiary lymphoid structures in pancreatic cancer immunotherapy pathologic responders.
    Sidiropoulos DN; Shin SM; Wetzel M; Girgis AA; Bergman D; Danilova L; Perikala S; Shu DH; Montagne JM; Deshpande A; Leatherman J; Dequiedt L; Jacobs V; Ogurtsova A; Mo G; Yuan X; Lvovs D; Stein-O'Brien G; Yarchoan M; Zhu Q; Harper EI; Weeraratna AT; Kiemen AL; Jaffee EM; Zheng L; Ho WJ; Anders RA; Fertig EJ; Kagohara LT
    bioRxiv; 2024 Sep; ():. PubMed ID: 39386736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment.
    Chelvanambi M; Fecek RJ; Taylor JL; Storkus WJ
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33526609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer.
    Di Modugno F; Di Carlo A; Spada S; Palermo B; D'Ambrosio L; D'Andrea D; Morello G; Belmonte B; Sperduti I; Balzano V; Gallo E; Melchionna R; Panetta M; Campo G; De Nicola F; Goeman F; Antoniani B; Carpano S; Frigè G; Warren S; Gallina F; Lambrechts D; Xiong J; Vincent BG; Wheeler N; Bortone DS; Cappuzzo F; Facciolo F; Tripodo C; Visca P; Nisticò P
    EBioMedicine; 2024 Mar; 101():105003. PubMed ID: 38340557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer.
    Meylan M; Petitprez F; Becht E; Bougoüin A; Pupier G; Calvez A; Giglioli I; Verkarre V; Lacroix G; Verneau J; Sun CM; Laurent-Puig P; Vano YA; Elaïdi R; Méjean A; Sanchez-Salas R; Barret E; Cathelineau X; Oudard S; Reynaud CA; de Reyniès A; Sautès-Fridman C; Fridman WH
    Immunity; 2022 Mar; 55(3):527-541.e5. PubMed ID: 35231421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapy.
    Langouo Fontsa M; Padonou F; Willard-Gallo K
    Expert Rev Clin Immunol; 2024 Aug; 20(8):839-847. PubMed ID: 39007892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy is associated with suppression of the B cell-centered immune landscape in pancreatic ductal adenocarcinoma.
    Rupp L; Dietsche I; Kießler M; Sommer U; Muckenhuber A; Steiger K; van Eijck CWF; Richter L; Istvanffy R; Jäger C; Friess H; van Eijck CHJ; Demir IE; Reyes CM; Schmitz M
    Front Immunol; 2024; 15():1378190. PubMed ID: 38629072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells.
    Goc J; Germain C; Vo-Bourgais TK; Lupo A; Klein C; Knockaert S; de Chaisemartin L; Ouakrim H; Becht E; Alifano M; Validire P; Remark R; Hammond SA; Cremer I; Damotte D; Fridman WH; Sautès-Fridman C; Dieu-Nosjean MC
    Cancer Res; 2014 Feb; 74(3):705-15. PubMed ID: 24366885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers.
    Dieu-Nosjean MC; Giraldo NA; Kaplon H; Germain C; Fridman WH; Sautès-Fridman C
    Immunol Rev; 2016 May; 271(1):260-75. PubMed ID: 27088920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The enrichment of the gut microbiota Lachnoclostridium is associated with the presence of intratumoral tertiary lymphoid structures in hepatocellular carcinoma.
    Zhao R; Li J; Chen B; Zhao J; Hu L; Huang K; Chen Q; Yao J; Lin G; Bao L; Lu M; Wang Y; Chen G; Wu F
    Front Immunol; 2023; 14():1289753. PubMed ID: 38116013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tertiary Lymphoid Structure Raises Survival and Immunotherapy in HPV
    Li H; Zhu SW; Zhou JJ; Chen DR; Liu J; Wu ZZ; Wang WY; Zhang MJ; Sun ZJ
    J Dent Res; 2023 Jun; 102(6):678-688. PubMed ID: 36883630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.